Exogene

London, United Kingdom

Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening.

$186K raised

Oct 2025

Equity Crowdfunding

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Exogene raised?

Exogene has raised $186K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in October 2025.

Who are Exogene's investors?

Exogene's investors include Entrepreneurs First, R42 Group, Unruly Capital, Jude Gomila, Selvedge Venture.

Where is Exogene headquartered?

Exogene is headquartered in London, United Kingdom.

What does Exogene do?

Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening.

What stage is Exogene at?

Exogene is at the Equity Crowdfunding stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 1, 2025.

MLA

"Exogene — Funding & Investors." VCBacked, October 1, 2025, https://www.vcbacked.co/company/exogene. Accessed July 2, 2026.

APA

VCBacked. (2025). Exogene — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/exogene

Wikipedia (cite web)

{{cite web |title=Exogene — Funding & Investors |url=https://www.vcbacked.co/company/exogene |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 1, 2025.